A Multi-site Bridging Study of Nalfurafine Hydrochloride Orally Disintegrating Tablet
Clinical trial NCT04728984 · UNKNOWN
Trial details
- NCT number
- NCT04728984
- Sponsor
- Shenyang Sunshine Pharmaceutical Co., LTD.
- Status
- UNKNOWN
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2020-09-07
- Primary completion
- 2021-06-30
- Enrollment
- 135
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.